The influence of certain genes, such as DNA2, EGFR, FAIM, and HEATR3, on glioma risk, which is mediated through alterations in telomere length, enhances the elucidation of pathogenic mechanisms and introduces novel strategies for targeting telomere‐related pathways. This evidence concerns the gene EGFR and central nervous system cancer.